TickerFacts.

Niagen Bioscience, Inc. (NAGE): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-01-03 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$29.87M
As of 2025-12-31
$24.06M
As of 2026-06-30
+5.6%
3-year compound annual growth
+6.4%
5-year compound annual growth
+8.3%
10-year compound annual growth
2012-12-29: $5.04M2013-12-28: $3.32M2015-01-03: $7.52M2016-01-02: $13.47M2016-12-31: $9.78M2017-12-30: $8.89M2018-12-31: $15.05M2019-12-31: $19.80M2020-12-31: $21.93M2021-12-31: $26.11M2022-12-31: $25.39M2023-12-31: $26.51M2024-12-31: $22.18M2025-12-31: $29.87M$29.87M
2012-12-29 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$29.87M+34.7%2026-03-04, Balance as of period end
2024-12-31$22.18M-16.3%2026-03-04, Balance as of period end
2023-12-31$26.51M+4.4%2025-03-04, Balance as of period end
2022-12-31$25.39M-2.8%2024-03-06, Balance as of period end
2021-12-31$26.11M+19.1%2023-03-08, Balance as of period end
2020-12-31$21.93M+10.8%2022-03-14, Balance as of period end
2019-12-31$19.80M+31.5%2021-03-12, Balance as of period end
2018-12-31$15.05M+69.3%2020-03-10, Balance as of period end
2017-12-30$8.89M-9.1%2019-03-07, Balance as of period end
2016-12-31$9.78M-27.4%2018-03-15, Balance as of period end
2016-01-02, Fiscal 2015$13.47M+79.2%2017-03-16, Balance as of period end
2015-01-03, Fiscal 2014$7.52Mn/c2016-03-17, Balance as of period end
2013-12-28$3.32M-34.1%2015-03-19, Balance as of period end
2012-12-29$5.04Mn/a2014-03-27, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Niagen Bioscience, Inc. (NAGE)2025-12-31$29.87M+34.7%
Natural Alternatives International Inc (NAII)2025-06-30$83.51M+4.7%
Cronos Group Inc. (CRON)2025-12-31$54.18M-2.1%
Mannatech Inc (MTEX)2025-12-31$35.22M+28.3%
Marimed Inc. (MRMD)2025-12-31$137.83M+6.5%
Glass House Brands Inc. (GLAS)2025-12-31$143.96M-1.7%
biote Corp. (BTMD)2025-12-31$158.01M-29.6%
Fitlife Brands, Inc. (FTLF)2025-12-31$62.68M+179.8%
Jushi Holdings Inc. (JUSH)2025-12-31$537.69M+9.6%

Compare NAGE, NAII, CRON, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗